In this companion article, Brenda Heath, RN, discusses key challenges related to the use of leuprolide acetate and leuprolide mesylate from an organizational management perspective.
Brenda Heath, RN
Advertisement
Articles by Brenda Heath, RN
In the fourth interview of the series, Brenda Heath, RN, shares expert insights into key factors related to nurse training on leuprolide administration, inventory management of the drug, and patient support programs.
In this companion article, Brenda Heath, RN, reflects on practical considerations in the preparation and administration of formulations of leuprolide acetate and leuprolide mesylate.
In the second interview of the series, Brenda Heath, RN, examines special considerations in the preparation and administration of formulations of leuprolide acetate and leuprolide mesylate.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Urology Times
1
Christof Vulsteke, MD, PhD, breaks down findings, implications of KEYNOTE-905
2
The UroOnc Minute: Active Surveillance for Intermediate-risk Prostate Cancer, with Michael Leapman, MD, MHS
3
Petros Grivas, MD, on the significance of a perioperative regimen for cisplatin-ineligible MIBC
4
The Significance of KEYNOTE-905 in Muscle-Invasive Bladder Cancer
5
